Precision In, Precision Out: Elevated Kitting Strategies for Clinical Trials
Date: May 22, 2025
Duration: 60 Minutes
Register to Watch Webinar On Demand
Topics covered
- Which kit design approaches actually make life easier for clinical sites—and why that’s critical for trial success
- What really happens when sample preservation goes wrong—and how to prevent it
- How custom kitting solutions can be tailored to meet even the most complex protocol requirements
- What agile approaches can help you stay on track when protocols shift unexpectedly
- Which training and support tactics reduce site errors and improve compliance
- Which sample management approaches can elevate your entire biomarker operations

-
It provided key information to be taken into consideration for the design and preparation of sample collection, sample handling, storage and shipping of biological samples. What must be done in advance to prevent delays and what to do if study protocol changes during the conduct of the clinical trial.
—Clinical project leader, Spain -
The detail was helpful on the slides and the Examples with time references were crutial to understanding.
— Research Manager, USA -
Good insights into the sample workstream and critical impact points.
—Associate Director, Clinical Data Management, USA -
Covered much of the preparation required for specialized kitting/sampling. Good information on how PFM deals with all of this.
—VP Clinical Development, USA
Speakers
-
Christie Bongel, MS, CT(ASCP)
Christie Bongel, Site Director at Precision For Medicine. She brings nearly two decades of experience in both research and clinical medicine. As the site director for Precision for Medicine’s IHC Center of Excellence in North Carolina, she excels in managing scientific operations and collaborating with clients. Christie is skilled in cytology, laboratory medicine, and molecular diagnostics. Christie earned her MS in Applied Biotechnology and is an ASCP certified cytotechnologist.
(SizeLimitingPyList: [linkedin])
-
Deb Phippard, PhD
Deb Phippard, Chief Scientific Officer at Precision for Medicine. Pharma industry veteran and expert at biomarker-driven clinical trial design and execution. Leader of biomarker and drug development programs for pharmaceutical and diagnostics companies, as well as the National Institutes of Health. Spearheaded the discovery of pharmacodynamic biomarkers and novel targets for inflammatory disease therapy.
(SizeLimitingPyList: [linkedin])